States Begin Detailing Specific Use of 150 Million BinaxNOW COVID-19 Tests Distributed by Trump Administration

Four weeks after the Trump Administration announced it would deploy 150 million state-of-the-art Abbott BinaxNOW COVID-19 tests nationally to assist Governors’ ongoing reopening efforts, states have begun to report back where they are choosing to distribute the rapid, point of care tests. Of the states who have provided preliminary reports, use of the BinaxNOW allocations are largely being deployed to local health departments, K-12 schools and institutes of higher education, nursing homes, hospitals and correctional facilities.

“To protect seniors and to facilitate the continued re-opening of schools, businesses and the economy, the Trump Administration prioritized scaling-up our state and national point of care testing capacity,” said Assistant Secretary for Health Admiral Brett Giroir, MD. “Through strategic deployment of rapid tests to higher-risk individuals, accompanied by Federal surge- testing of individuals where there are outbreaks – as was the case this summer in multiple Sunbelt states – our national plan to provide the right test, at the right time, to the right person is working.”